The main mediators of tumour angiogenesis are both the two VEGFA isoforms, that is, the soluble VEGF121 and VEGF165, although the principal signalling tyrosine kinase receptor is the VEGF receptor 2 (VEGFR‐2; FLK, KDR in humans). The gene discussed is VEGFA; the disease is neoplasm.